Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function

Current Urology Reports

Volumn 2, Issue 4, 2001, Pages 311-317

  Hoznek, András ^a   Abbou, Clément Claude ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Benign Prostatic Hyperplasia; Erectile Dysfunction; Holmium Laser; Lower Urinary Tract Symptom; Transurethral Resection

Indexed keywords

HUMAN; MALE; MALE GENITAL SYSTEM SURGERY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION;

HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; UROLOGIC SURGICAL PROCEDURES, MALE;

EID: 0035427997     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-001-0070-4     Document Type: Article

References (48)

1. O’Leary MP: LUTS, ED, QOL: alphabet soup or real concerns to aging men? Urology 2001, 56:7–11. During the last decade there was a change in the philosophy concerning the interpretation and relative value of outcome variables of BPH. This is an excellent update of the available evaluation tools concerning quality of life and sexuality related to lower urinary tract symptoms. DOI: 10.1016/S0090-4295(00)00742-1
2. Blaivas JG: The bladder is an unreliable witness. Neurourol Urodyn 1996, 15:443–445. DOI: 10.1002/(SICI)1520-6777(1996)15:5<443::AID-NAU1>3.0.CO;2-F
3. Donovan JL, Peters TJ, Abrams P, et al.: Scoring the short form ICSmaleSF questionnaire. International Continence Society. J Urol 2000, 164:1948–1955. DOI: 10.1016/S0022-5347(05)66926-1
4. Donovan JL, Kay HE, Peters TJ, et al.: Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-‘BPH’ Study. International Continence Society—Benign Prostatic Hyperplasia. Br J Urol 1997, 80:712–721.
5. Hansen BJ, Mortensen S, Mensink HJ, et al.: Comparison of the Danish Prostatic Symptom Score with the International Prostatic Symptom Score, the Madsen-Iversen and Boyarsky symptom indexes. ALFECH Study Group. Br J Urol 1998, 81:36–41.
6. Barry MJ, Fowler FJ, O’Leary MP, et al.: Measuring disease-spe-cific health status in men with benign prostatic hyperplasia. Measurement Committee of the American Urological Association. Med Care 1995, 33:AS145-AS155. DOI: 10.1097/00005650-199508000-00003
7. Cappelleri JC, Siegel RL, Osterloh IH, Rosen RC: Relationship between patient self-assessment of erectile function and the erectile function domain of the international index of erectile function. Urology 2000, 56:477–481. DOI: 10.1016/S0090-4295(00)00697-X
8. O’Leary MP, Fowler FJ, Lenderking WR, et al: A brief male sexual function inventory for urology. Urology 1995, 46:697–706. DOI: 10.1016/S0090-4295(99)80304-5
9. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC: Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989, 141:243–247.
10. Horninger W, Unterlechner H, Strasser H, Bartsch G: Transurethral prostatectomy: mortality and morbidity. Pros-tate 1996, 28:195–200. DOI: 10.1002/(SICI)1097-0045(199603)28:3<195::AID-PROS6>3.0.CO;2-E
11. Uchida T, Ohori M, Soh S, et al.: Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology 1999, 53:98–105. DOI: 10.1016/S0090-4295(98)00524-X
12. Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP: Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999, 162:1307–1310. DOI: 10.1016/S0022-5347(05)68272-9
13. Chander J, Gupta U, Mehra R, Ramteke VK: Safety and efficacy of transurethral resection of the prostate under sedoanalgesia. BJU Int 2001, 86:220–222. DOI: 10.1046/j.1464-410x.2000.00754.x
14. Birch BR, Gelister JS, Parker CJ, Chave H, Miller RA: Transurethral resection of prostate under sedation and local anesthesia (sedoanalgesia). Experience in 100 patients. Urology 1991, 38:113–118. DOI: 10.1016/S0090-4295(05)80069-X
15. Hanbury DC, Sethia KK: Erectile function following transurethral prostatectomy. Br J Urol 1995, 75:12–13.
16. Tscholl R, Largo M, Poppinghaus E, Recker F, Subotic B: Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative Snap Gauge tests. J Urol 1995, 153:1491–1493. DOI: 10.1016/S0022-5347(01)67442-1
17. Soderdahl DW, Knight RW, Hansberry KL: Erectile dysfunction following transurethral resection of the prostate. J Urol 1996, 156:1354–1356. DOI: 10.1016/S0022-5347(01)65585-X
18. Bieri S, Iselin CE, Rohner S: Capsular perforation localization and adenoma size as prognostic indicators of erectile dysfunctional after transurethral prostatectomy. 1997, Scand J Urol Nephrol 31:545–548. DOI: 10.3109/00365599709030660
19. Yarnitsky D, Sprecher E, Vardi Y: Penile thermal sensation. J Urol 1996, 156:391–393. DOI: 10.1016/S0022-5347(01)65857-9
20. Lefaucheur JP, Yiou R, Salomon L, Chopin DK, Abbou CC: Assessment of penile small nerve fiber damage after transurethral resection of the prostate by measurement of penile thermal sensation. J Urol 2000, 164:1416–1419. An original and promising approach to the neurophysiologic evaluation of surgery-induced erectile dysfunction. In the future, such objective investigations will be increasingly required due to the increasing demand of surgery minimizing sexual sequelae. DOI: 10.1016/S0022-5347(05)67209-6
21. Ornstein DK, Rao GS, Smith DS, Andriole GL: The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate. J Urol 1997, 157:880–883; discussion 883–884. DOI: 10.1016/S0022-5347(01)65072-9
22. Talic RF, Al Kudair WK, El Tiraifi AE, et al.: The ‘Wing’ versus the ‘Vapor Cut’ electrodes in transurethral electrovaporization-resection of the prostate: comparative changes in safety parameters. Urol Int 2000, 65:95–99. DOI: 10.1159/000064847
23. Yajima M, Baba K, Yanagisawa N, et al.: Clinical study of transurethral surgery for benign prostatic hyperplasia using a thick loop (VaporTome). Hinyokika Kiyo 2000, 46:247–250.
24. Kupeli S, Soygur T, Yilmaz E, Budak M: Combined transurethal resection and vaporization of the prostate using newly designed electrode: a promising treatment alternative for benign prostatic hyperplasia. J Endourol 1999, 13:225–228.
25. Perlmutter AP, Vallancien G: Thick loop transurethral resection of the prostate. Eur Urol 1999, 35:161–165. DOI: 10.1159/000019837
26. Ishikawa N, Goya N, Iguchi Y, et al.: Comparison of the depth of the desiccated zone with selected vaporizing-cutting electrodes: a basic study in animals. BJU Int 2000, 85:754–758. DOI: 10.1046/j.1464-410x.2000.00512.x
27. Talic RF, Al Rikabi AC: Transurethral vaporization-resection of the prostate versus standard transurethral prostatectomy: comparative changes in histopathological features of the resected specimens. Eur Urol 2000, 37:301–305. DOI: 10.1159/000052360
28. Talic RF: Transurethral electrovaporization-resection of the prostate using the “wing” cutting electrode: preliminary results of safety and efficacy in the treatment of men with prostatic outflow obstruction. Urology 1999, 53:106–110. DOI: 10.1016/S0090-4295(98)00437-3
29. Talic RF, El Tiraifi A, El Faqih SR, et al.: Prospective randomized study of transurethral vaporization resection of the prostate using the thick loop and standard transurethral prostatectomy. Urology 2000, 55:886–890. DOI: 10.1016/S0090-4295(00)00520-3
30. Moody JA, Lingeman JE: Holmium laser enucleation for prostate adenoma greater than 100 gm: comparison to open prostatectomy. J Urol 2001, 165:459–462. DOI: 10.1097/00005392-200102000-00025
31. Gilling PJ, Kennett KM, Fraundorfer MR: Holmium laser resection v transurethral resection of the prostate: results of a randomized trial with 2 years of follow-up. J Endourol 2000, 14:757–760. This is a rigorous and informative study that provides essential information on the current status and future role of laser resection of the prostate. DOI: 10.1089/end.2000.14.757
32. Gilling PJ, Mackey M, Cresswell M, et al.: Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup. J Urol 1999, 162:1640–1644. DOI: 10.1016/S0022-5347(05)68186-4
33. Le Duc A, Gilling PJ: Holmium laser resection of the prostate. Eur Urol 1999, 35:155–160. DOI: 10.1159/000019836
34. Matsuoka K, Iida S, Tomiyasu K, Shimada A, Noda S: Transurethral holmium laser resection of the prostate. J Urol 2000, 163:515–518. DOI: 10.1016/S0022-5347(05)67914-1
35. Floratos DL, Kiemeney LA, Rossi C, Kortmann BB, Debruyne FM, de la Rosette JJ: Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol 2001, 165:1533–1538. A well-designed study allowing a better understanding of the relative merits of thermotherapy and traditional transurethral resection of the prostate. DOI: 10.1016/S0022-5347(05)66343-4
36. Francisca EA, D’Ancona FC, Meuleman EJ, Debruyne FM, de la Rosette JJ: Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999, 161:486–490. DOI: 10.1016/S0022-5347(01)61930-X
37. Arai Y, Aoki Y, Okubo K, et al.: Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. J Urol 2000, 164:1206–1211. DOI: 10.1016/S0022-5347(05)67142-X
38. D’Ancona FC, Francisca EA, Hendriks JC, Debruyne FM, de la Rosette JJ: The predictive value of baseline variables in the treatment of benign prostatic hyperplasia using high-energy transurethral microwave thermotherapy. Br J Urol 1998, 82:808–813.
39. Bolmsjo M, Sturesson C, Wagrell L, Andersson-Engels S, Mattiasson A: Optimizing transurethral microwave thermotherapy: a model for studying power, blood flow, temperature variations and tissue destruction. Br J Urol 1998, 81: 811–816.
40. Djavan B, Bursa B, Basharkhah A, et al.: Pretreatment prostate-specific antigen as an outcome predictor of targeted transurethral microwave thermotherapy. Urology 2000, 55:51–57. DOI: 10.1016/S0090-4295(99)00364-7
41. Muschter R, Schorsch I, Danielli L, et al.: Transurethral water-induced thermotherapy for the treatment of benign prostatic hyperplasia: a prospective multicenter clinical trial. J Urol 2000, 164:1565–1569. DOI: 10.1016/S0022-5347(05)67029-2
42. Arai Y, Okubo K, Okada T, Maekawa S, Aoki Y, Maeda H: Interstitial laser coagulation for management of benign prostatic hyperplasia: a Japanese experience. J Urol 1998, 159:1961–1965. DOI: 10.1016/S0022-5347(01)63210-5
43. Kletscher BA, Oesterling JE: Transurethral incision of the prostate: a viable alternative to transurethral resection. Semin Urol 1992, 10: 265–272.
44. Riehmann M, Knes JM, Heisey D, Madsen PO, Bruskewitz RC: Transurethral resection versus incision of the prostate: a randomized, prospective study. Urology 1995, 45:768–775. DOI: 10.1016/S0090-4295(99)80081-8
45. Graversen PH, Gasser TC, Larsen EH, Dorflinger T, Bruskewitz RC: Transurethral incisions of the prostate under local anaesthesia in high-risk patients: a pilot study. Scand J Urol Nephrol Suppl 1987, 104:87–90.
46. Irani I, Bon D, Fournier F, Dore B, Aubert J: Patient acceptability of transurethral incision of the prostate under local anaesthesia. Br J Urol 1996, 78:904–906.
47. Yang Q, Abrams P, Donovan J, Mulligan S, Williams G: Transurethral resection or incision of the prostate and other therapies: a survey of treatments for benign prostatic obstruction in the UK. BJU Int 1999, 84:640–645. DOI: 10.1046/j.1464-410x.1999.00276.x
48. Jepsen JV, Bruskewitz RC: Recent developments in the surgical management of benign prostatic hyperplasia. Urology 1998 51: 23–31. DOI: 10.1016/S0090-4295(98)00052-1